STOCK TITAN

Exact Sciences schedules fourth quarter 2022 earnings call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Exact Sciences Corp. (NASDAQ: EXAS) has announced that it will release its fourth quarter 2022 financial results on February 21, 2023, after U.S. market close. A webcast and conference call will follow at 5 p.m. ET to discuss the results and ongoing business developments. Interested parties can access the live webcast on the company's website. The company is recognized for its cancer screening and diagnostic tests, including Cologuard and Oncotype, and continues to invest in its product pipeline to support patients throughout their cancer journey.

Positive
  • None.
Negative
  • None.

MADISON, Wis., Feb. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2022 financial results after the close of the U.S. financial markets on February 21, 2023. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

Fourth quarter 2022 webcast & conference call details

Date:           

Tuesday, February 21, 2023

Time:             

5 p.m. ET

Webcast:     

The live webcast can be accessed at www.exactsciences.com

Telephone:       

Domestic callers, dial 888-330-2384


International callers, dial +1 240-789-2701


Access code for both domestic and international callers: 4437608

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-770-2030 domestically or +1 647-362-9199 internationally. The access code for the replay of the call is 4437608. The webcast, conference call, and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-fourth-quarter-2022-earnings-call-301735685.html

SOURCE Exact Sciences Corporation

FAQ

When will Exact Sciences release its fourth quarter 2022 financial results?

Exact Sciences will release its fourth quarter 2022 financial results on February 21, 2023.

What time is the conference call for Exact Sciences' Q4 2022 earnings?

The conference call for Exact Sciences' Q4 2022 earnings will take place at 5 p.m. ET on February 21, 2023.

How can I access the Exact Sciences' Q4 2022 earnings webcast?

The live webcast for Exact Sciences' Q4 2022 earnings can be accessed on their official website.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.16B
185.08M
1%
99.1%
8.41%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON